Diamedix Email Format
Biotechnology ResearchUnited States11-50 Employees
Diamedix operates in the biotechnology research field with a focus on medical diagnostic technologies. The company traces its roots to Cordis Laboratories and has been active for more than 25 years. It has developed immunodiagnostic innovations across its products, procedures, and integrated instrument and reagent systems for autoimmune and infectious disease detection. Its product systems aim to simplify and improve diagnostic testing by enhancing efficiency and accuracy while promoting economy. Based in the United States, Diamedix maintains a small-to-mid-sized team serving customers in the autoimmune and infectious disease testing space. In 2020 the company divested assets to CoStar Group as part of corporate activities.